Last update 15 Sep 2025

QLC1401

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
QLC1401
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication
Advanced breast cancerER-positive/HER2-negative Breast Cancer
Inactive Indication-
Originator Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
Active Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.Shenzhen Yangli Pharmaceutical Technology Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with QLC1401
CTR20253558
/ Not yet recruitingPhase 1/2
评价QLC1401片联合CDK4/6抑制剂或mTOR抑制剂在雌激素受体阳性（ER+）、人表皮生长因子受体2阴性（HER2-）局部晚期或转移性乳腺癌患者的安全性和耐受性、有效性及药代动力学特征的Ib/Ⅱ期临床研究
[Translation] A Phase Ib/II clinical study evaluating the safety and tolerability, efficacy, and pharmacokinetic characteristics of QLC1401 tablets combined with a CDK4/6 inhibitor or an mTOR inhibitor in patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer
100 Clinical Results associated with QLC1401
Login to view more data
100 Translational Medicine associated with QLC1401
Login to view more data
100 Patents (Medical) associated with QLC1401
Login to view more data
100 Deals associated with QLC1401
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced breast cancerPhase 2-
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
01 Sep 2025
ER-positive/HER2-negative Breast CancerPhase 2-
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
01 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free